◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›ARWR

ARWR (ARWR)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

Insider Monkey·vor 1 Tagen

Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?

Business Wire·vor 5 Tagen

Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress

MT Newswires·vor 9 Tagen

Arrowhead Pharmaceuticals Insider Sold Shares Worth $1,012,680, According to a Recent SEC Filing

MT Newswires·vor 12 Tagen

Arrowhead Pharmaceuticals' Redemplo Now Available in Germany for FCS Patients

Business Wire·vor 12 Tagen

People Living with Familial Chylomicronaemia Syndrome (FCS) in Germany Have Access to REDEMPLO® (plozasiran) as a New Treatment Option to Reduce Triglycerides

BioPharma Dive·vor 22 Tagen

‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit

Frag BlackSpecter AI über ARWR

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist ARWR kaufenswert?ARWR Earnings Analyse ARWR Bewertung

AI Chat öffnen →